Short answer: not clearly. A DEA registration on its own has not been shown to end 280E. The final order says state licensees will no longer be subject to Section 280E as a consequence of the rule, but it also says the rule is not a determination of federal tax liability. Treasury’s April 23 release ties relief to businesses that no longer traffic in Schedule I or II substances, and it does not make DEA registration a condition. If you run a licensed business, talk to tax counsel now and watch for the Treasury and IRS guidance, which decides the details.
Status as of November 2, 2026.
What the final order says about 280E
The final order, published April 28, 2026, moves FDA-approved products containing marijuana, and products containing marijuana under a qualifying state-issued license, from Schedule I to Schedule III. Its tax passage says state licensees will no longer be subject to the Section 280E deduction disallowance as a consequence of the rule. The same passage says the rule is not a determination of federal tax liability, and that qualifying state licensees should consult tax counsel. You can read the final order text on the Justice Department site.
What Treasury and the IRS said in April
Treasury’s April 23 release explains the tax side in more detail. Section 280E generally bars deductions and credits for a business whose activity is trafficking in Schedule I or II substances. Rescheduling generally lifts that bar for businesses that, because of the order, stop trafficking in those substances. Treasury and the IRS say they plan to issue guidance on the details.
| Point | What the Treasury release says |
|---|---|
| General rule | Relief generally applies to businesses that no longer traffic in Schedule I or II substances as a result of the order |
| DEA registration | Not made a stated condition |
| Mixed businesses | Guidance expected to limit 280E to activities tied to Schedule I or II substances, for example by apportioning expenses |
| Transition rule | Guidance expected to treat rescheduling as first applying to the business’s full taxable year that includes the order’s effective date |
| Earlier years | Relief for earlier years is not described |
The April release describes that guidance as forthcoming. Whether it has been issued since then is a question for Treasury and the IRS.
Does DEA registration change the 280E picture?
This is the question most people are searching for, and no source answers it yet. Treasury’s release ties its relief to what a business does under the order, and it does not make registration a stated condition. The Associated Press framed registration as something that “could pave the way for tax benefits long denied the industry.” That describes a possible path, not a rule that registration ends 280E.
The final order also links the DEA registration to the state license. If a state medical marijuana license is suspended, revoked or expires, the DEA registration is automatically suspended.
Which businesses have DEA registrations?
On October 30, 2026, the Justice Department’s registration release announced the first phase of federal registrations for qualifying state-licensed medical marijuana dispensaries. The initial group includes more than 900 dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia. Each had to finish DEA’s pre-registration investigation first. The release also says state licensure alone does not automatically grant federal registration.
The names of the registered dispensaries are not public. The Justice Department release does not name them, and the Associated Press reported the department did not immediately identify the approved businesses. A separate report from Cannabis Business Times says DEA’s list of timely applicants gives business types and states, not business names. That list counts 4,197 dispensaries, 2,086 manufacturers and 710 distributors. Manufacturer and distributor applications are still under review, including facility inspections, production controls and quota decisions.
Minnesota and dual-market states
Minnesota is the clearest case so far. A DEA order to show cause was delivered to a Minneapolis dispensary. Marijuana Moment reports that the order was signed by Cheri Oz, assistant administrator of DEA’s Diversion Control Division. It says a dual-purpose license permitting both medical and non-medical dispensing falls outside the definition of a state medical marijuana license. The order gives two options: request a hearing before an administrative law judge within 30 days, or submit a corrective action plan.
Some coverage calls this a denial. The DEA guidance treats an application as ended only by withdrawal or a Final Order denying it, so the Minnesota document is an order to show cause, not a settled denial.
Minnesota’s Office of Cannabis Management says the letter does not affect the state law that authorizes its medical and adult-use programs. Cannabis Business Times reports that 30 Minnesota businesses filed timely applications, including 26 dispensaries.
Carol Moss, an Edina-based cannabis attorney, told the Minnesota Star Tribune that the biggest effect falls on businesses in dual-market states, which will not get the Schedule III tax advantages even if they do no recreational business. She added that if the problem is state law, the owner probably has little room to correct it. Attorney Neil Willner of Vicente LLP said DEA appears to be testing whether a whole state can be disqualified, rather than judging individual applicants.
Marijuana Moment also notes that state adult-use programs do not issue doctors’ written certifications, so it is unclear how adult-use businesses could register even if broader rescheduling is adopted.
Supply chains and the November 29 date
DEA’s guidance for timely applicants, dated October 30, 2026, covers entities that submitted a complete application, including the fee, between April 28 and June 26, 2026. While an application is pending, those timely applicants may dispense, manufacture or distribute schedule III medical marijuana under their state license. They are expected to finish verification and set up compliant supply chains by November 29, 2026.
The guidance says dealing with entities outside that group could be grounds for denying a timely applicant’s application or revoking a registration. It also says it does not have the force of law and is not meant to bind the public.
The broader rescheduling case is separate
The Justice Department says marijuana outside the order remains Schedule I, and broader rescheduling is being considered in a separate administrative proceeding. Adult-use cannabis stays in Schedule I while that process runs, with no clear timeline. The broader hearing concluded July 15, 2026. On October 22, DEA’s Chief Administrative Law Judge declined to reopen it, and the process remains on hold until at least November 5, according to Cannabis Business Times. For background, read still confused about federal marijuana law, and for workplace testing questions, see dot drug tests and marijuana rescheduling.
Key dates
| Date | What it covers |
|---|---|
| April 28 to June 26, 2026 | Window for timely applications, including the fee, under the April 28 final rule |
| October 30, 2026 | DEA guidance for timely applicants issued; DOJ registration release |
| November 5, 2026 | Replies due in the broader rescheduling proceeding (briefs were due October 29); the process remains on hold until at least this date |
| November 29, 2026 | Timely applicants expected to complete verification and establish compliant supply chains |
| 30 days | Minnesota order to show cause: window to request an administrative law judge hearing, or submit a corrective action plan |
What is still open
- Whether DEA registration on its own changes 280E treatment, given that Treasury ties relief to trafficking and does not make registration a stated condition.
- How apportionment will work for businesses with multiple activities, and how the transition rule applies to each business’s taxable year that includes the effective date.
- Whether Treasury and the IRS have issued the expected guidance.
- Whether dual-license and dual-market businesses, such as the Minnesota applicants, will keep any registration or tax treatment after the order to show cause is resolved.
- What requirements DEA may impose, including on owners with criminal histories, according to the Associated Press.
- How DEA will buy and resell marijuana and coordinate with states. Gillian Schauer of the Cannabis Regulators Association raised both questions.
- Which dispensaries are registered, since their names have not been made public.
Until Treasury and the IRS issue their guidance, whether registration alone changes 280E treatment stays open.
By HealthDataConsortium.org Research Team
